Fake endorsements and misleading marketing Peaka GLP-1 marketing materials frequently feature celebrity endorsements and doctor recommendations that appear to be fabricated
Injectable treatments, including Wegovy shots and Eli Lilly's Zepbound, begin at $299 per month when paid for without insurance, Amazon said
The average half-life of lixisenatide is approximately 34 h
Regardless of the method, remember that these medications are designed to support a healthy lifestyle, not replace it
Functionality, Nutrition, and Product Innovation GLP-1 meal replacement manufacturers are prioritizing: High-protein and nutrient-dense formulations Portion-controlled and lower-sugar meal solutions Digestive-support and satiety-support blends Multi-format product offerings across RTDs, powders, bars, and savory formats Functional nutrition designed specifically for reduced-appetite routines Innovation is increasingly focused on balancing convenience, tolerance, nutritional relevance, and taste appeal
J Endocr Soc 2021:5
